Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AROA BIOSURGERY LIMITED Major Shareholding Notification 2021

Aug 29, 2021

64426_rns_2021-08-29_c9f3d582-b641-42cd-831f-9e9e54b86a1f.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

605 Page 1 of 2 15 July 2001

Form 605

Corporations Act 2001

Section 671B

Notice of ceasing to be a substantial holder

To Company Name/Scheme Aroa Biosurgery Ltd ACN/ARSN 638 867 473

1. Details of substantial holder (1)

Name Movac Fund 3 Limited Partnership / Movac Limited

ACN/ARSN (if applicable)

The holder ceased to be a substantial holder on 30 / 08 / 2021 The previous notice was given to the company on 28 / 01 / 2021 The previous notice was dated 28 / 01 / 2021

2. Changes in relevant interests

Particulars of each change in, or change in the nature of, a relevant interest (2) of the substantial holder or an associate (3) in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:

Date of
change
Person whose
relevant interest
changed
Nature of change (4) Consideration given in
relation to change (5)
Class (6) and
number of
securities affected
Person's votes
affected
30/08/
2021
Movac Fund 3
Limited
Partnership
/ Movac
Limited
Distribution
of shares by
Movac Fund 3
Limited
Partnership
N/A (in specie
distribution
to partners of
Movac Fund 3
Limited
Partnership)
18,679,050
ordinary
shares
18,679,050
ordinary
shares

3. Changes in association

The persons who have become associates (3) of, ceased to be associates of, or have changed the nature of their association (7) with, the substantial holder in relation to voting interests in the company or scheme are as follows:

Name and ACN/ARSN (if applicable) Nature of association N/A N/A

4. Addresses

The addresses of persons named in this form are as follows:

Name Address
Movac Fund 3 Limited
Partnership
PO Box 1170 Manners Street, Wellington, 3011, New Zealand
Movac Limited Level 3, 2/12 Allen Street, Wellington, 6011, New Zealand

Signature

print name David Beard capacity Director

605 Page 2 of 2 15 July 2001

date 30 / 08 / 2021

sign here

==> picture [43 x 46] intentionally omitted <==

DIRECTIONS

  • (1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 4 of the form.

  • (2) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.

  • (3) See the definition of "associate" in section 9 of the Corporations Act 2001.

  • (4) Include details of:

  • (a) any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

  • (b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

  • (5) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

  • (6) The voting shares of a company constitute one class unless divided into separate classes.

  • (7) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.